Financials

  • Market Capitalization 27.02 M
  • Employee 70
  • Founded 2005
  • CEO N/A
  • Website www.igcinc.us
  • Headquarter Maryland, United States
  • FIGI BBG000NSSLY8
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.29
Relación precio/flujo de caja
19.33

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4480
KYNB
Kyntra Bio, Inc. - Common Stock
7.05 USD+0.28%-0.14%-2.62%-25.87%28.54 M USD
4485
ACTU
Actuate Therapeutics, Inc. - Common stock
1.15 USD-2.54%-18.44%-33.53%-71.81%27.51 M USD
4495
BTAI
BioXcel Therapeutics, Inc. - Common Stock
0.87 USD+2.35%-2.25%-32.03%-44.94%26.86 M USD
4497
ATNM
Actinium Pharmaceuticals, Inc. Common Stock
0.85 USD-1.16%-4.49%-14.14%-18.27%26.67 M USD

Noticias